#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary angioedema Cerebral arteriovenous malformation haemorrhagic Shprintzen-Goldberg syndrome Phaeochromocytoma Partial lipodystrophy Alternating hemiplegia of childhood Brain abscess Fatty acid oxidation disorder Chemical burn Myxofibrosarcoma Hairy cell leukaemia Turner's syndrome Paraganglion neoplasm Small intestine leiomyosarcoma Metabolic disorder More trials…

    Learn about Rare Diseases

    Progressive multifocal leukoencephalopathy – Basic Information Hereditary motor and sensory neuropathy – Treatment Mantle cell lymphoma stage III – Diagnostics Marfan’s syndrome – Life with Disease Krabbe’s disease – Treatment Bronchopulmonary dysplasia – Basic Information Haemophilia A without inhibitors Hereditary hypophosphataemic rickets – Diagnostics Richter’s syndrome – Treatment Ornithine transcarbamoylase deficiency – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pentoxifylline Human Vaccinia Immunoglobulin Absk021 Hydrochloride Hydrate Levoleucovorin Disodium Sodium Cromoglicate Ceftriaxone Ucp2 MARALIXIBAT Festuca Rubra Pollen Sabirnetug Desflurane Aaa802 Syn321 Mosunetuzumab Tamibarotene Escitalopram Oxalate ANHYDROUS CALCIUM FOLINATE Alisertib Sodium Brexpiprazole Fumarate Retinol Palmitate More therapies…

    Learn about Your Condition

    Primary hyperthyroidism Glomerulonephritis membranous Colon cancer stage IV Pancreatitis relapsing Tuberculosis Cystic fibrosis Malignant melanoma stage IV Cholangiocarcinoma Leukaemia Prostate cancer recurrent Upper limb fracture Glanzmann's disease Head and neck cancer Cutaneous sarcoidosis Hyperparathyroidism primary More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Embolism

  • Study of REGN7508 versus apixaban for treating and preventing cancer-associated blood clots in adults with solid or blood cancers

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Regn7508
    • Apixaban
    Bulgaria Romania

  • Comparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    • Apixaban
    • Enoxaparin Sodium
    Bulgaria Hungary Latvia Lithuania Poland Romania

  • A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    Belgium Bulgaria Czechia France Germany Poland +2

  • A study to compare REGN7508 and acetylsalicylic acid for preventing blood clots in adults undergoing elective total knee replacement.

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Regn7508
    • Acetylsalicylic Acid
    Greece Italy Spain

  • A study to compare how asundexian is absorbed in healthy adults using different formulations and the effect of food for the prevention of blood clots.

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Asundexian
    Germany

  • Study comparing apixaban tablets to test if they work the same way in the body in healthy volunteers who have not eaten

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Apixaban
    Spain
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!